Why Eli Lilly’s CFO Sees Cancer Drugs as the Next Growth Drivers

Eli Lilly posts earnings that handily top estimates, fueled by strong performance in its metabolic portfolio. Continue Reading

Doc ban tin day du cua Veytics

Chung toi hien cong khai y chinh. Tao tai khoan mien phi de doc toan bo bai viet, luu, thao luan va ket noi voi boi canh thi truong va OSINT.